PATENT CLAIM ANALYSIS

Application Number: 15863132
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "468000"]

Abstract:
The invention provides naphthofuran compounds, polymorphs of naphthofuran compounds, naphthofuran compounds in particle form, purified compositions that contain one or more naphthofuran compounds, purified compositions that contain one or more naphthofuran compounds in particle form, methods of producing these naphthofuran compounds, polymorphs, purified compositions and/or particle forms, and methods of using these naphthofuran compounds, polymorphs, purified compositions and/or particle forms to treat subjects in need thereof.

Claim (Index 13):
A method of prolonging progression free survival (PFS) in a cancer patient, the method comprising administering to a human subject in need thereof a therapeutically effective amount of the compound according to  claim 1 , or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 86.0
- Lexical Diversity: 2.48387
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14642931', '13634694', '13634676', '12677513', '14002986']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7421998879555346
- 35 USC 102 Novelty (BERT): 0.597434080269669
- Combined Prediction Score: 0.727723307186948
- Mean Citation Score: 417.440162
- Max Citation Score: 543.513
- Similarity Product: 427.6921203187108

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test